Long-term follow-up of clinical trials of multiple sclerosis therapies

@article{Freedman2011LongtermFO,
  title={Long-term follow-up of clinical trials of multiple sclerosis therapies},
  author={M. Freedman},
  journal={Neurology},
  year={2011},
  volume={76},
  pages={S26 - S34}
}
  • M. Freedman
  • Published 2011
  • Medicine
  • Neurology
  • Results from registry studies can provide valuable information about the prevalence and clinical course of different forms of multiple sclerosis (MS). Such studies can also help identify medical practice patterns in a real-world setting and important risk factors that may affect long-term outcomes in patients with MS. To date, however, these observational studies have provided less information than well-planned, randomized, controlled trials on the long-term treatment effects of disease… CONTINUE READING
    69 Citations

    Figures, Tables, and Topics from this paper

    Paper Mentions

    Interventional Clinical Trial
    Purpose of study is to determine safety and efficacy of use of autologous Adipose-Derived cellular Stromal Vascular Fraction (AD-cSVF) suspended in Normal Saline and delivered via… Expand
    ConditionsAutoimmune, Multiple Sclerosis
    InterventionDevice, Procedure
    Clinical outcome measures in multiple sclerosis.
    • 46
    Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis.
    • 13
    Multiple sclerosis: effect of beta interferon treatment on survival.
    • 10
    • PDF
    Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice
    • 8
    Improving adherence to injectable disease-modifying drugs in multiple sclerosis
    • A. Bayas
    • Medicine
    • Expert opinion on drug delivery
    • 2013
    • 23

    References

    SHOWING 1-10 OF 59 REFERENCES
    Course of multiple sclerosis
    • 83
    The natural history of secondary progressive multiple sclerosis
    • 213
    • PDF
    Eight-year follow-up study of brain atrophy in patients with MS
    • 352
    • PDF